Welcome to our dedicated page for Mccormick & Co SEC filings (Ticker: MKC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The McCormick & Company, Incorporated Non-VTG CS (NYSE: MKC) SEC filings page brings together the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. McCormick, a global flavor manufacturer of herbs, spices, seasonings, condiments, and flavors, reports its financial condition, results of operations, and material events through forms such as the annual report on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K.
Investors reviewing MKC filings can see how McCormick presents net sales, organic sales growth, gross profit, operating income, adjusted operating income, net income, and earnings per share, along with reconciliations of non-GAAP measures to GAAP results. The company also files 8-Ks to furnish earnings press releases, provide updates on its fiscal outlook, and disclose significant events. Examples include 8-K filings related to second and third quarter results and to the agreement and completion of the acquisition of an additional 25% ownership interest in McCormick de Mexico S.A. de C.V., a joint venture formed in 1947 with Grupo Herdez.
Through these filings, readers can track segment performance for the Consumer and Flavor Solutions businesses, as well as commentary on factors such as commodity costs, tariffs, foreign currency, and the impact of the Comprehensive Continuous Improvement (CCI) program. Current reports also describe transactions like the McCormick de Mexico ownership increase and reference associated press releases.
Stock Titan enhances access to these documents with AI-powered summaries that highlight key points from lengthy filings, including 10-K and 10-Q reports and 8-K disclosures. Real-time updates from EDGAR, combined with AI explanations, can help users quickly understand changes in McCormick’s reported results, outlook, and material events without manually parsing every page.
MCCORMICK & CO INC director Michael Aaron Conway reported an exercise and conversion of restricted stock units into common shares. On February 15, 2026, 2,222 Restricted Stock Units were converted at a price of $0.00 per unit, reflecting that no purchase price was required.
The transaction delivered 2,222 shares of Common Stock - Voting, increasing his directly held common stock to 18,852 shares after the transaction. The footnotes state these Restricted Stock Units entitle him to receive an annual distribution of common stock equal to 100% of the grant and were originally granted on February 7, 2025.
McCormick & Co. director Jacques Tapiero exercised 2,222 Restricted Stock Units on February 15, 2026, converting them into the same number of Common Stock - Voting shares at no purchase price. Following this derivative conversion, he directly holds 33,818.054 voting common shares and 2,620 non-voting common shares. The filing also shows his phantom stock balance at 0, with prior phantom stock tied to a Non-Qualified Retirement Savings Plan that settles in voting common stock under that plan’s terms.
McCormick & Company, Incorporated 10% owner Lawrence Erik Kurzius reported exercising options for 50,000 shares of voting common stock at an exercise price of $49.025 per share, with no cash purchase price required under the option terms. On the same day, he sold 50,000 shares of voting common stock in an open-market transaction at $71.63 per share. After these transactions, he directly owned 296,992 shares of voting common stock and 205,538 options representing rights to buy additional shares.
McCormick & Company Chairman, President and CEO Brendan M. Foley filed a Schedule 13D reporting significant ownership of the company’s common stock. He beneficially owns 790,496 shares of common stock, representing 5.1% of the outstanding class, including 648,975 shares that could be acquired within 60 days through stock options and restricted stock units.
The filing explains that Foley receives a substantial portion of his compensation in equity under McCormick’s incentive and retirement plans. He states that he currently has no specific plans to change control or pursue major corporate actions but may acquire additional shares or dispose of shares in the future as circumstances warrant. Recent equity-related activity includes phantom stock accruals in a non-qualified retirement plan, an award of 20,198 shares under a long-term incentive program, and a grant of 68,855 restricted stock units.
McCormick & Co. director Michael D. Mangan reported exercising and selling shares of the company’s stock. On February 9, 2026, he exercised 5,000 options with an exercise price of $49.96 per share, converting them into voting common stock, with no cash purchase price required.
That same day, he sold 5,000 shares of McCormick voting common stock at a price of $67.92 per share, leaving him with 43,029 shares of voting common stock and 4,234 shares of non‑voting common stock held directly. After the exercise, the reported option position was reduced to zero.
McCormick & Co. reported an equity grant to its top executive. Chairman, President & CEO Brendan M. Foley received an award of 68,855 Restricted Stock Units on February 6, 2026, at a stated price of $0 per unit. Each unit represents a contingent right to receive one share of voting common stock.
The Restricted Stock Units are scheduled to vest in three equal installments on February 15, 2027, February 15, 2028 and February 15, 2029. After this grant, Foley directly holds 68,855 Restricted Stock Units, 128,972.016 shares of voting common stock, and 1,371.457 shares of non‑voting common stock, along with an interest in phantom stock under a non‑qualified retirement savings plan.
McCormick & Co. officer Sarah Piper reported an equity award and updated share holdings. On February 6, 2026, she received 8,656 Restricted Stock Units, each representing a contingent right to one share of McCormick common stock.
The 8,656 Restricted Stock Units vest in three equal installments on March 15, 2027, March 15, 2028 and March 15, 2029. Following this grant, Piper directly beneficially owned 8,656 Restricted Stock Units and 9,631.04 shares of McCormick voting common stock, and held phantom stock through a Non-Qualified Retirement Savings Plan as described in the footnotes.
McCormick & Company officer Andrew Foust, President, Americas, received an award of 13,378 Restricted Stock Units on February 6, 2026. Each unit represents a contingent right to receive one share of McCormick common stock.
The RSUs vest in three equal parts on February 15, 2027, February 15, 2028, and February 15, 2029, encouraging longer-term retention. After this grant, Foust directly holds 13,378 derivative RSUs, along with 13,032.51 shares of Common Stock – Voting and 334.44 shares of Common Stock – Non Voting.
McCormick & Company executive Gregory Repas reported an equity grant in a Form 4 filing. On February 6, 2026, he was awarded 1,968 Restricted Stock Units, each representing a contingent right to receive one share of McCormick common stock.
The RSUs vest in three equal installments on February 15, 2027, February 15, 2028, and February 15, 2029, encouraging longer-term retention. After this award, Repas directly beneficially owned 1,968 RSUs and 2,266 shares of McCormick voting common stock.
McCormick & Company vice president receives new stock-based award. On 02/06/2026, officer Jeffery D. Schwartz was granted 14,952 Restricted Stock Units, each representing a contingent right to receive one share of McCormick common stock.
The RSUs vest in three equal parts on March 15, 2027, March 15, 2028, and March 15, 2029, linking compensation to longer-term performance and retention. After this grant, Schwartz directly holds 14,952 RSUs, 91,308 shares of voting common stock, and 246 shares of non‑voting common stock.